Adzynma
rADAMTS13
Purpura, Thrombotic Thrombocytopenic
Opinion date:
Last updated:
MedicineHumanOpinion
Nplate
romiplostim
Purpura, Thrombocytopenic, Idiopathic
Date of authorisation:
Revision: 27
Last updated:
MedicineHumanAuthorised
EMEA-001196-PIP03-21 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Haematology-HemostaseologyImmunology-Rheumatology-Transplantation
PIP number: P/0027/2022
Route(s) of administration: All routes of administration
Pharmaceutical form(s):
All pharmaceutical forms
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Doptelet
avatrombopag
Thrombocytopenia
Date of authorisation:
Revision: 7
Last updated:
MedicineHumanAuthorised
EMEA-001136-PIP01-11-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0010/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Powder for oral suspension
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Flebogamma DIF (previously Flebogammadif)
human normal immunoglobulin
Mucocutaneous Lymph Node Syndrome
Guillain-Barre Syndrome
Bone Marrow Transplantation
Purpura, Thrombocytopenic, Idiopathic
Immunologic Deficiency Syndromes
Date of authorisation:
Revision: 19
Last updated:
MedicineHumanAuthorised
EMEA-001136-PIP02-19-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0482/2020
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Powder for oral suspension
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Revolade
eltrombopag
Purpura, Thrombocytopenic, Idiopathic
Date of authorisation:
Revision: 34
Last updated:
MedicineHumanAuthorised
Privigen
human normal immunoglobulin (IVIg)
Purpura, Thrombocytopenic, Idiopathic
Bone Marrow Transplantation
Immunologic Deficiency Syndromes
Guillain-Barre Syndrome
Mucocutaneous Lymph Node Syndrome
Date of authorisation:
Revision: 31
Last updated:
MedicineHumanAuthorised